HCV NS3 protease inhibitors

Details for Australian Patent Application No. 2007309546 (hide)

Owner Merck & Co., Inc. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.

Inventors Liverton, Nigel J.; Pompei, Marco; Di Francesco, Maria Emilia; Vacca, Joseph P.; Summa, Vincenzo

Agent Spruson & Ferguson

Pub. Number AU-A-2007309546

PCT Pub. Number WO2008/051477

Priority 60/853,837 24.10.06 US

Filing date 19 October 2007

Wipo publication date 2 May 2008

International Classifications

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/051477 Priority application(s): WO2008/051477

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.; Merck Sharp & Dohme Corp.

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309553-System and device for supporting a breast shield

2007309544-HCV NS3 protease inhibitors